Mice deficient for CCR6 fail to control chronic experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 213, Issue 1-2, 2009, Pages 91-99

  Elhofy, Adam ^a   DePaolo, R William ^a   Lira, Sergio A ^b   Lukacs, Nicholas W ^c   Karpus, William J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

CCL20; CCR6; Central nervous system; Chemokine; EAE; Multiple sclerosis

Indexed keywords

CHEMOKINE RECEPTOR CCR6; GAMMA INTERFERON; INTERLEUKIN 17; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL MIGRATION; CHRONIC DISEASE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; HISTOLOGY; IMMUNIZATION; IMMUNOPATHOLOGY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; T LYMPHOCYTE; WILD TYPE;

ANIMALS; ANTIGENS, CD80; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNE TOLERANCE; INTERFERON-GAMMA; INTERLEUKIN-17; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; PEPTIDES; RECEPTORS, CCR6; SPLEEN; T-LYMPHOCYTES;

EID: 68049115475     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.05.011     Document Type: Article

References (48)

1. Ambrosini E., Columba-Cabezas S., Serafini B., Muscella A., and Aloisi F. Astrocytes are the major intracerebral source of macrophage inflammatory protein-3α/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro. Glia 41 (2003) 290-300
2. Baba M., Imai T., Nishimura M., Kakizaki M., Takagi S., Hieshima K., Nomiyama, and Yoshie O. Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J. Biol. Chem. 272 (1997) 14893-14898
3. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., and Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
4. Brosnan C.F., Bornstein M.B., and Bloom B.R. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J. Immunol. 126 (1981) 614-620
5. Brown J.A., Dorfman D.M., Ma F.R., Sullivan E.L., Munoz O., Wood C.R., Greenfield E.A., and Freeman G.J. Blockade of programmed death-1 ligands on dendritic cells enhances t cell activation and cytokine production. J. Immunol. 170 (2003) 1257-1266
6. Carter L.L., Leach M.W., Azoitei M.L., Cui J., Pelker J.W., Jussif J., Benoit S., Ireland G., Luxenberg D., Askew G.R., Milarski K.L., Groves C., Brown T., Carito B.A., Percival K., Carreno B.M., Collins M., and Marusic S. PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 182 (2007) 124-134
7. Cook D.N., Prosser D.M., Forster R., Zhang J., Kuklin N.A., Abbondanzo S.J., Niu X.D., Chen S.C., Manfra D.J., Wiekowski M.T., Sullivan L.M., Smith S.R., Greenberg H.B., Narula S.K., Lipp M., and Lira S.A. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 12 (2000) 495-503
8. 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab. Invest. 63 (1990) 162-170
9. Dieu-Nosjean M.C., Massacrier C., Homey B., Vanbervliet B., Pin J.J., Vicari A., Lebecque S., Dezutter-Dambuyant C., Schmitt D., Zlotnik A., and Caux C. Macrophage inflammatory protein 3α is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J. Exp. Med. 192 (2000) 705-718
10. Dogan R.N., Elhofy A., and Karpus W.J. Production of CCL2 by central nervous system cells regulates development of murine experimental autoimmune encephalomyelitis through the recruitment of TNF- and iNOS-expressing macrophages and myeloid dendritic cells. J. Immunol. 180 (2008) 7376-7384
11. Fife B.T., Guleria I., Gubbels Bupp M., Eagar T.N., Tang Q., Bour-Jordan H., Yagita H., Azuma M., Sayegh M.H., and Bluestone J.A. Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J. Exp. Med. 203 (2006) 2737-2747
12. Flugel A., Berkowicz T., Ritter T., Labeur M., Jenne D.E., Li Z., Ellwart J.W., Willem M., Lassmann H., and Wekerle H. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 14 (2001) 547-560
13. Gabrilovich D.I., and Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev., Immunol. 9 (2009) 162-174
14. Greaves D.R., Wang W., Dairaghi D.J., Dieu M.C., Saint-Vis B., Franz-Bacon K., Rossi D., Caux C., McClanahan T., Gordon S., Zlotnik A., and Schall T.J. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3α and is highly expressed in human dendritic cells. J. Exp. Med. 186 (1997) 837-844
15. Hickey W.F. Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol. 1 (1991) 97-105
16. Hickey W.F., Hsu B.L., and Kimura H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28 (1991) 254-260
17. Hirata S., Senju S., Matsuyoshi H., Fukuma D., Uemura Y., and Nishimura Y. Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand. J. Immunol. 174 (2005) 1888-1897
18. Hohlfeld R., Kerschensteiner M., Stadelmann C., Lassmann H., and Wekerle H. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. J. Neuroimmunol. 107 (2000) 161-166
19. Holden T., and Maecker J.T. Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry Part A 69A (2006) 1037-1042
20. Huitinga I., Van Rooijen N., De Groot C.J.A., Uitdehaag B.M.J., and Dijkstra C.D. Elimination of macrophages infiltrating into the central nervous system suppresses experimental allergic encephalomyelitis in Lewis rats. Ann. N. Y. Acad. Sci. 594 (1990) 458-460
21. Karpus W.J., and Ransohoff R.M. Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J. Immunol. 161 (1998) 2667-2671
22. Karpus W.J., Lukacs N.W., McRae B.L., Strieter R.M., Kunkel S.L., and Miller S.D. An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155 (1995) 5003-5010
23. Karpus W.J., Kennedy K.J., Smith W.S., and Miller S.D. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide. J. Neurosci. Res. 45 (1996) 410-423
24. Karpus W.J., Fife B.T., and Kennedy K.J. Immunoneutralization of chemokines for the prevention and treatment of central nervous system autoimmune disease. Methods 29 (2003) 362-368
25. + T-cell subset. Blood 105 (2005) 2877-2886
26. Kohler R.E., Caon A.C., Willenborg D.O., Clark-Lewis I., and McColl S.R. A role for macrophage inflammatory protein-3α/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous system. J. Immunol. 170 (2003) 6298-6306
27. Korn T., Reddy J., Gao W., Bettelli E., Awasthi A., Petersen T.R., Backstrom B.T., Sobel R.A., Wucherpfennig K.W., Strom T.B., Oukka M., and Kuchroo V.K. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13 (2007) 423-431
28. + T cell cytokine profile in experimental allergic encephalomyelitis. Eur. J. Immunol. 27 (1997) 2840-2847
29. Kuchroo V.K., Sobel R.A., Laning J.C., Martin C.A., Greenfield E., Dorf M.E., and Lees M.B. Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein. Fine specificity and T cell receptor Vβ usage. J. Immunol. 148 (1992) 3776-3782
30. Latchman Y.E., Liang S.C., Wu Y., Chernova T., Sobel R.A., Klemm M., Kuchroo V.K., Freeman G.J., and Sharpe A.H. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10691-10696
31. Liang S.C., Latchman Y.E., Buhlmann J.E., Tomczak M.F., Horwitz B.H., Freeman G.J., and Sharpe A.H. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 33 (2003) 2706-2716
32. Liao F., Rabin R.L., Smith C.S., Sharma G., Nutman T.B., and Farber J.M. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3α. J. Immunol. 162 (1999) 186-194
33. Liston A., Kohler R.E., Townley S., Haylock-Jacobs S., Comerford I., Caon A.C., Webster J., Harrison J.M., Swann J., Clark-Lewis I., Korner H., and McColl S.R. Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response. J. Immunol. 182 (2009) 3121-3130
34. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., Miller L.H., Oppenheim J.J., and Power C.A. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52 (2000) 145-176
35. Ortler S., Leder C., Mittelbronn M., Zozulya A.L., Knolle P.A., Chen L., Kroner A., and Wiendl H. B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: implications for the lesion pathogenesis of multiple sclerosis. Eur. J. Immunol. 38 (2008) 1734-1744
36. Reboldi A., Coisne C., Baumjohann D., Benvenuto F., Bottinelli D., Lira S., Uccelli A., Lanzavecchia A., Engelhardt B., and Sallusto F. C-C chemokine receptor 6-regulated entry of T(H)-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 10 (2009) 514-523
37. Schreiner B., Mitsdoerffer M., Kieseier B.C., Chen L., Hartung H.P., Weller M., and Wiendl H. Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. J. Neuroimmunol. 155 (2004) 172-182
38. Schutyser E., Struyf S., and Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 14 (2003) 409-426
39. Segal B.M., Dwyer B.K., and Shevach E.M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187 (1998) 537-546
40. Tokita D., Mazariegos G.V., Zahorchak A.F., Chien N., Abe M., Raimondi G., and Thomson A.W. High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. Transplantation 85 (2008) 369-377
41. Tuohy V.K., Sobel R.A., Lu Z., Laursen R.A., and Lees M.B. Myelin proteolipid protein: minimum sequence requirements for active induction of autoimmune encephalomyelitis in SWR/J and SJL/J mice. J. Neuroimmunol. 39 (1992) 67-74
42. Varona R., Zaballos A., Gutierrez J., Martin P., Roncal F., Albar J.P., Ardavin C., and Marquez G. Molecular cloning, functional characterization and mRNA expression analysis of the murine chemokine receptor CCR6 and its specific ligand MIP-3α. FEBS Lett. 440 (1998) 188-194
43. Varona R., Villares R., Carramolino L., Goya I., Zaballos A., Gutierrez J., Torres M., Martinez A., and Marquez G. CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses. J. Clin. Invest. 107 (2001) R37-R45
44. + regulatory T cells. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 9331-9336
45. Whitham R.H., Bourdette D.N., Hashim G.A., Herndon R.M., Ilg R.C., Vandenbark A.A., and Offner H. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 146 (1991) 101-107
46. Yamazaki T., Yang X.O., Chung Y., Fukunaga A., Nurieva R., Pappu B., Martin-Orozco N., Kang H.S., Ma L., Panopoulos A.D., Craig S., Watowich S.S., Jetten A.M., Tian Q., and Dong C. CCR6 regulates the migration of inflammatory and regulatory T cells. J. Immunol. 181 (2008) 8391-8401
47. Zhu B., Guleria I., Khosroshahi A., Chitnis T., Imitola J., Azuma M., Yagita H., Sayegh M.H., and Khoury S.J. Differential role of programmed death-1 ligand and programmed death-2 ligand in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis. J. Immunol. 176 (2006) 3480-3489
48. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 (2000) 121-127